⚠ You're viewing a report from May 2022. Subscribe to get the latest →

FDA Enforcement — May 2022 Report

Automated analysis of 64 items from public government data sources. Updated daily.

Summary

64
Total items
36
High impact
28
Medium impact
0
Low impact

High-impact items this period

Re-Gen Active Lab, Inc.
HCT/P regulatory deviation and CFR non-compliance
Why: Human cells/tissues product handling violations and regulatory deviations  ·  May 27  ·  Impact: HIGH
Smitha C. Reddy, M.D./ACRC Studies, LLC
Clinical investigator protocol compliance violations
Why: Deviations from clinical investigation regulations and requirements  ·  May 27  ·  Impact: HIGH
Haniel Concepts, Inc. DBA Free State Oils, LLC
Unapproved CBD products marketed illegally
Why: Selling CBD products with unauthorized drug claims  ·  May 26  ·  Impact: HIGH
Hope Botanicals, LLC
Unapproved CBD products marketed as drugs
Why: Selling CBD products without FDA approval as drug claims  ·  May 26  ·  Impact: HIGH
Plantacea, LLC dba Kahm
Unapproved CBD products marketed without authorization
Why: Distributing misbranded CBD products making drug claims  ·  May 26  ·  Impact: HIGH
Aire-Master of America, Inc.
Finished pharmaceutical product CGMP adulteration
Why: Current Good Manufacturing Practice violations in production  ·  May 23  ·  Impact: HIGH
Grimann S.A. de C.V.
Failed drug registration and listing requirements
Why: Non-compliance with FDA drug establishment registration and listing  ·  May 23  ·  Impact: HIGH
MMWTA Mothers Milk WTA
Tobacco product adulterated or misbranded under FSPTCA
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  May 20  ·  Impact: HIGH
Santhigram Kerala Ayurvedic Co. of U.S., Inc.
Sale and distribution of unapproved new drugs
Why: Marketing unapproved Ayurvedic products as pharmaceutical drugs  ·  May 19  ·  Impact: HIGH
New Vitalis, LLC dba New Vitalis Pharmacy
Compounding pharmacy producing adulterated drug products
Why: Pharmacy compounding violations producing contaminated medications  ·  May 18  ·  Impact: HIGH

Selected medium-impact items

Daxa Foods, Inc. dba India Grocers
Foreign supplier verification program violations
Why: Failure to implement adequate FSVP procedures  ·  May 31  ·  Impact: MEDIUM
Export Guatemala Corporation
Inadequate foreign supplier verification procedures
Why: Failure to comply with FSVP requirements for imported food products  ·  May 31  ·  Impact: MEDIUM
Dara Food LLC
FSVP non-compliance for foreign supplier verification
Why: Failure to implement adequate foreign supplier verification program  ·  May 31  ·  Impact: MEDIUM
BonZer BrandZ LLC d/b/a BonZer VapeZ, LLC
Tobacco product adulterated/misbranded violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  May 27  ·  Impact: MEDIUM
Freeman and Biddy, LLC d/b/a Freedom Vapes
Tobacco products adulterated and misbranded
Why: Non-compliant vapor products violating tobacco control regulations  ·  May 26  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →